“THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR CAS9 AS PROSTATE CANCER THERAPY”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia 9, no. 1 (July 12, 2021): 23–37. Accessed June 15, 2026. https://jimki.bapin.or.id/main/article/view/321.